Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × dacomitinib × 90 days × Clear all

NCT03810807 2025-12-23

Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung